Barclays’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-143
| Closed | -$20K | – | 5464 |
|
|
2022
Q1 | $20K | Sell |
143
-645
| -82% | -$94.2K | ﹤0.01% | 4456 |
|
|
2021
Q4 | $135K | Buy |
788
+523
| +197% | +$195K | ﹤0.01% | 3669 |
|
|
2021
Q3 | $133K | Buy |
265
+185
| +231% | +$85.8K | ﹤0.01% | 3791 |
|
|
2021
Q2 | $40K | Sell |
80
-11
| -12% | -$5.91K | ﹤0.01% | 4238 |
|
|
2021
Q1 | $46K | Buy |
+91
| New | +$46.9K | ﹤0.01% | 4218 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6614 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7006 |
|
|
2019
Q3 | – | Sell |
-417
| Closed | -$48K | – | 7301 |
|
|
2019
Q2 | $48K | Buy |
417
+322
| +339% | +$51K | ﹤0.01% | 6120 |
|
|
2019
Q1 | $16K | Buy |
+95
| New | +$16.3K | ﹤0.01% | 6438 |
|
|
2018
Q4 | – | Sell |
-122
| Closed | -$19K | – | 7511 |
|
|
2018
Q3 | $19K | Buy |
122
+103
| +542% | +$43.1K | ﹤0.01% | 6486 |
|
|
2018
Q2 | $13K | Sell |
19
-81
| -81% | -$60.6K | ﹤0.01% | 6427 |
|
|
2018
Q1 | $102K | Buy |
+100
| New | +$83.7K | ﹤0.01% | 5369 |
|
|
2017
Q3 | – | Sell |
-71
| Closed | -$11K | – | 7128 |
|
|
2017
Q2 | $11K | Buy |
71
+55
| +344% | +$11.1K | ﹤0.01% | 6037 |
|
|
2017
Q1 | $4K | Buy |
16
+13
| +433% | +$3.49K | ﹤0.01% | 6352 |
|
|
2016
Q4 | $1K | Buy |
+3
| New | +$715 | ﹤0.01% | 6519 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6874 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | -$1.09K | – | 6734 |
|
|
2016
Q1 | $0 | Buy |
+1
| New | +$673 | ﹤0.01% | 6537 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6762 |
|
|
2015
Q3 | – | Sell |
-32
| Closed | -$26.8K | – | 7147 |
|
|
2015
Q2 | $19K | Sell |
32
-161
| -83% | -$172K | ﹤0.01% | 5715 |
|
|
2015
Q1 | $406K | Buy |
193
+185
| +2,313% | +$315K | ﹤0.01% | 3789 |
|
|
2014
Q4 | $7K | Sell |
8
-4
| -33% | -$4.27K | ﹤0.01% | 6894 |
|
|
2014
Q3 | $12K | Buy |
12
+2
| +20% | +$3.37K | ﹤0.01% | 6796 |
|
|
2014
Q2 | $24K | Buy |
10
+1
| +11% | +$2.04K | ﹤0.01% | 6428 |
|
|
2014
Q1 | $15K | Hold |
9
| – | – | ﹤0.01% | 6739 |
|
|
2013
Q4 | $19K | Buy |
9
+6
| +200% | +$14.2K | ﹤0.01% | 6748 |
|
|
2013
Q3 | $7K | Sell |
3
-2
| -40% | -$3.87K | ﹤0.01% | 6911 |
|
|
2013
Q2 | $8K | Buy |
+5
| New | +$7.94K | ﹤0.01% | 7226 |
|
Other funds holding AMPE
PCMC
CFO
E
AAP
Barclays's AMPE Position: Q2 2022 in Review
Barclays sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2022, closing a stake of 143 shares — an estimated $20K sold.
Barclays first reported a position in AMPE in Q2 2013 and held it in 23 quarters. The position peaked at $406K in Q1 2015. 111 funds tracked by Wall St. Rank hold AMPE as of Q2 2022.
- Barclays reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2022 after selling out during the quarter.
- Barclays sold 143 Ampio Pharmaceuticals Inc. shares in Q2 2022, an estimated $20K.
- Barclays first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 23 quarters.
- Barclays's Ampio Pharmaceuticals Inc. position peaked at $406K in Q1 2015.
- 111 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2022.
Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.